The results revealed that the plant extract showed a significant induction of sperm abnormalities at the three concentrations used comparing with the untreated animals. The administration of a single injection of 0.767gm/kg of C. roseus extract to twenty pregnant females mice on the day 10 through 16 of gestation period did not show any apparent malformations. However, compared with the control population of the pup's number, body length, and head length was significantly reduced within the first day of life. Overall, those finding indicate that Catharanthus roseus aqueous extract can induce significant mitotic inhibition, slight chromosome aberrations and micronuclei frequencies and it can bring about significant percentage of abnormal spermatozoa, besides its ability to cross placental barrier causing some growth retardation; rather than teratogenic effects.
Introduction
Catharanthus roseus (L.) G.Don, Apocynaceae, formerly called Vinca rosea (L.), is an ornamental, annual evergreen perennial shrub that occurs naturally in most warm regions of the world, including Iraq (1) . It has been used in traditional medicine by various societies to treat various kinds of leukemia, skin cancer, lymph cancer, breast cancer, Hodgkin's disease (2), diabetes, hypertension, fever and hemostasis (3) .There are several other usages for this plant such as for the treatment of Malaria, a remedy for sore throat, for controlling bleeding, for treatment of dyspepsia, indigestion and dysmenorrheal (4) .Catharanthus roseus has become one of the most interesting plants in the pharmaceutical industry, because it contains more than 120 terpenoid indole alkaloids (TIAs), and many of the alkaloids exhibit strong pharmacological activities (5) . Previous studies have identified significant active compounds in C. roseus, including vinblastine and vincristine (anticancer), ajmalicine (antihypertensive) and serpentine (sedative) (5; 6) . In spite of widespread use of this precious plant in different parts of the world, it had never been used in Kurdistan of Iraq folk remedy and to the best of our knowledge, there is no published data on the cytotoxicity, genotoxicity and teratogenicity of C. roseus leaves crude extract. Therefore the purpose of this study was to ensure the efficiency and safety of using the aqueous leaves extract of this herb to treat cancer, diabetes and other diseases, as did other countries, by testing its cytotoxicity, genotoxicity and teratogenicity properties in vivo.
Materials and Methods

A-Collection and extraction of Catharanthus roseus
Healthy, disease free, mature leaves of Catharanthus roseus pink variety was collected locally from Duhok University gardens. A voucher specimen of the plant was deposited to be identified and authenticated at the Agriculture and Forestry herbarium of Duhok University (Certificate number (4447) in (23/5/2014) A modified method of Roy & Chatterjee (7) was used for the preparation of the aqueous extract of C roseus; the dried leaves of the plant were ground to a fine powder using electric grinder and then the powder were suspended in distilled water for 12 hours, at the rate of 50 gm/200 ml; the obtained extract has been twice filtered through whattman No.42 filter paper and a clean brown filtrate was obtained. The filtrate was concentrated to semi dryness under reduced pressure and controlled temperature (40 -47°C) using rotary evaporator. A deep brown colored residue was obtained, which was incubated in a clean Petri dish overnight at (37°C) to obtain about 25% yield of extract. Finally the extract was kept in a dark closed container (-4°C) and was used during 1-5 days.
B-Animals and experimental design
Cytogenetic and cytotoxic experiments were carried out on 8-10-week-old male Swiss albino mice (Mus musculus) Balb/c, weighing 25-30 g. They were maintained in a controlled atmosphere of 12 h dark/light cycle, 25±2°C temperature and had free access to food and water supply. The mice were divided into experimental groups of 5 animals. An extract of C roseus leaves was administered in a 
C-Cytotoxic assay: 1 -Determination of LD50:
The LD50 was determined using the classical LD50 method according to Behrens and Karbers (8) . Graded single doses of C roseus (4, 6, 8, 10 , and 12) gm/kg were administrated subcutaneously to five groups of mice, each of which consisted of six mice. Mortality was recorded after 24 hours.
D-Cytogenetic assays 1) Micronucleus (MN) assay:
Micronucleus (MN) assay, were prepared as recommended by Schimid (9) . The slides were coded, fixed with methanol and stained with Giemsa solution. 500 polychromatic erythrocytes (PCE) from each animal were scored for micronucleus (MN) presence.
2) Mitotic index (MI)assay:
The 
3) Chromosome aberrations assay:
Bone marrow preparations from the femur bones were used for the analysis of chromosome aberrations in metaphase cells, using the technique of Evans and Ford (11) , for this test the extracts were administered daily for three consecutive days and the animals were sacrificed by cervical dislocation at 24, 48 and 72 hours after the third medication.
4) Spermatozoa abnormalities assay:
For the analysis of spermatozoa abnormalities, the mice were sacrificed five weeks after the last day of sub-acute treatment (12) .The spermatozoa were obtained by making small cuts in epididymis and vas deferens, placed in 1 ml of normal saline .The sperm suspension obtained was stained with 0.05% of eosin-Y; smears were made on slides, air-dried and made permanent.
E-Teratogenicity investigation
To investigate the teratogenicity effect of C. roseus, adult female and male Swiss albino mice (28-35gm) of proven fertility were used for this experiment. Forty females at (12) (13) (14) weeks of age were placed in the evening with mature males (2 female: 1 male). Copulation was checked by the presence of vaginal plug next morning or by the finding of sperm in the vaginal smear when vaginal plugs were less conspicuous than usual. When a plug was found or when spermatozoa were present, the females were separated and housed in groups for treatment. This time was called day zero of pregnancy. Twenty pregnant females were administered by a single subcutaneously injection at 0.767gm/kg body weight of C roseus aqueous extract on the day 10 through day 16 of gestation period. A further twenty pregnant mice were used as control group which received 1ml of PBS/day subcutaneously (13) . All animals were observed daily throughout pregnancy, and then all dams were allowed to deliver naturally. At birth pups were examined carefully for external anomalies and they were examined for body weight, body length and head length (measured with a Vernier caliper) on postnatal day one.
F-Statistical analysis
The data obtained were submitted to the statistical program SAS (2005), Mitotic Index, Micronuclei, Sperm abnormalities, and pregnancy outcome in mice were analyzed using Completely Randomized Design (CRD) Chromosome Aberrations were analyzed using factorial 3x5(CRD) to study the effect of treatments and P<0.05 was considered statistically significant.
Results and Discussion
A-Toxicity of C. roseus extract:
Determination of the median lethal dose of a test substance is considered one of the very important steps to be done in experimental animals before any other experimental tests. This is to aid choosing the appropriate dose that can be employed in an experiment.
The experimental calculated LD 50 value in this study was 7.67gm/kg of body weight as shown in table (1) . To the best of our knowledge, a very few data on acute and sub chronic toxicity of C. roseus extract were available, despite the widespread use of the plant in various herbal remedies. Generally this herb is poisonous if ingested or smoked; it can cause poisoning in grazing animals (14) In this study, some behavioural changes were observed after 8-10 hours of subcutaneously administration of a single dose of 6-10 gm/kg, those changes included the loss of appetite, restlessness, diarrhea, impermanent blindness, loss in body weight, nervousness.. Some of those behavioural changes may reflect the peripheral neurotoxicity of C. roseus alkaloids ( roseus is a microtubule toxin; the mechanism involves binding its alkaloids to the tubulin monomers and preventing microtubule polymerization thus keeping the microtubules (spindle fibres) from forming and preventing cell division during the M phase of cell cycle (19) .Moreover, C. roseus cytotoxicity was strongly correlated with both duration and concentration of drug treatment (20) . At high concentration, its alkaloids cause microtubule depolymerisation, dissolve spindle microtubules and arrest cells in mitosis. While At low concentrations, they suppress microtubule dynamics, induce cell cycle arrest and apoptosis, but do not depolymerize microtubules (21) . Similar results were obtained by El-Merzabani and colleagues (22) who explained that the leaves ethanol (70%) extract when administered intraperitoneally to female mice exhibited significant MI inhibition. 
D-Micronuclei Assay
The result in table (4) and figure (2) reveals that the highest dose 0.767gm/kg of the C. roseus extract caused the most significant induction of micronuclei in a dose dependent manner. It has been reported that spindle defects can directly generate double -strand DNA breaks (chromosome or chromatid break); those breaks localized in micronuclei and found adjacent to centromeres form the spindle attachment points in mitosis (26) So, in agreement with the result obtained in the current study and on the basis of the role of spindle, we suggest that chromosome breaks were generated in mitosis and segregation defects cause an increased frequency of lagging chromosomes leading to micronucleus occurrence in somatic cells of mice which may not reflect random chromosome break point positioning, but could result from small pieces of chromatin consisting of some centromeric materials. This may explain the significant centromeric chromosome fragment observed in this study. Similar reports are also available on the genotoxic effect of Vinblastine which was administered by single intraperitoneal doses (0.5, 1.0, and 1.5 mg/kg) to Swiss mice. It was found that Vinblastine increased numerous relatively large-sized MN after 30hr. of treatment in a dose dependent manner (24) . This study also agrees with other studies (27;23) which reveal that vincristine, Vinorelbine and Vinblastine induced a significant increase in micronuclei (MN) frequencies in binucleated (BN) cell, as well as producing slowing of the cell cycle, causing a decrease in the percentage of BN cells in cultured human lymphocytes and in female CD-1 mice. ( 29) .Another study proved the cytotoxic and genotoxic effects of vincristine on germ cells of male mice, vincristine administration resulted in damage to DNA in spermatocytes and spermatids, reduction in the rate of germ cell development, and killing of the non-proliferating spermatid cells (30) .
A through screening of literature revealed that the sperm morphological abnormalities may be due to a change in genetic material as the normal sperm head is very distinctive and any abnormalities might be influenced by genetic background (31;32).
However, the defect spindle of sperm nuclei which is expected in this study as a reflect of the exposure to C. roseus which could induce DNA double strand breaks as explained by Guerrero and his colleagues (26) . Thus, it brings about DNA damage of germ cells which may cause the observed sperm head abnormalities ( 
F-Teratogenicity evaluation
The number of animals delivered, average of offspring number, average of body weight, average body length and average of head length on postnatal day one are shown in table (6) ; only the average of offspring number, body length and pups head length were reduced significantly from corresponding control, as shown in figure ( 3) . No signs of deformities were observed in the treated mice. These results indicated absence of external teratogenic activity of the aqueous extract. The reduction of pup's number, body length, and head length may be due to the effect of C. roseus alkaloids such as vincristine, which could be strongly associated with the decreased mass of the ovary and uterus by its metabolization, therapeutic, toxicological or immunosuppressive action (33) . Furthermore, vincristine could easily cross the placental barrier (33) which means it is a trans placental genotoxicants in mice. So C. roseus alkaloids might transmit its action to the next generation as it affects both female and male germ cells, but Vinblastine in mice did not necessarily lead to teratogenic effects (34 ) . Moreover, no congenital malformations were noticed in 14 infants born to mothers treated with only vincristine (35) . In fact, the action of C. roseus alkaloids on causing cytotoxicity, genotoxicity, and teratogenicity are strongly correlated with both duration and concentration of the extract treatment. On the basis of the results obtained in the present study, causing genotoxicity in both somatic and germ cells of Balb/c albino mice by C. roseus aqueous extract may produce cellular changes which might play an important role in initiating growth defects (developmental alterations). However, further intensive long term studies are required to reveal these adverse effects.
Figure 3:
Show The reduction of pup's, body length, on postnatal day one, the pups were treated prenatally by a single subcutaneously injection at 0.767gm/kg body weight of C roseus extract on the day 10 through day 16 of gestation period. 
